Glimepiride 1mg, Metformin Hcl. (SR) 500mg Tablets
That mirrors expectations
Achieves good glycemic control with better tolerability profile Highly effective in patients having both
high fasting and high post-prandial blood glucose levels Produces beneficial effects even on abnormal lipid profile' After the intensive treatment, FPG, 2 hPG and HbAlc decreased significantly (P<0.01); HOMA-IR decreased and HOMA-B increased significantly (P<0.01) and TG, CHOL, LDL decreased significantly (P<0.01) after treatment"
Considered as an effective treatment for patients Inadequately controlled on sulfonylurea or Met alone2
"The addition of glimepiride to MET is an effective treatment for patients inadequately controlled on sulfonylurea or Met alone"
In
• Monotherapy-resistant diabetes mellitus
• Diabetes with abnormal lipid profile
• Diabetes with raised glycosylated Haemoglobin (HbA 1c
Also Available
Glimisense-M2
Glimepride 2mg, Metformin Hcl. (SR) 500 mg Tablets
Ref.: 1. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Mar; 31(3): 564 2. Pareek A et al. Am J Ther. 2011 Feb 15 Abbreviations: HOMA-IR: The Homeostasis Model of Assessment - Insulin Resistance
HOMA-B: The Homeostasis Model Assessment - Beta-cell function
Glimisense-M2
Glimepride 2mg, Metformin Hcl. (SR) 500 mg Tablets